Secondary analysis of two randomised trials (716 infants): seroinfection risk was similar for PCV10SII vs PCV10GSK on shared serotypes, lower for 6A and 19A. Vs PCV13, risk was lower for serotype 14 (RR 0.35) but higher for 6A (RR 2.27) and 6B (RR 2.91).
Secondary analysisn = 716
Akeju et al. Seroefficacy of a 10-valent pneumococcal conjugate vaccine (Pneumosil®) compared with other pneumococcal conjugate vaccines in children